{
  "id": 1936907,
  "title": "Earnings call transcript: Auna misses Q2 2026 profit view as revenue beats",
  "url": "https://urgent.news/2026/08/19/earnings-call-transcript-auna-misses-q2-2026-profit-view-as-revenue",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T12:45:48.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-auna-misses-q2-2026-profit-view-as-revenue-beats-93CH-4867450"
  },
  "original_language": "en",
  "account": "In Auna's second quarter 2026 earnings call, the company reported mixed results. Revenue of $1.24 billion surpassed Wall Street's estimate of $1.18 billion, while adjusted earnings per share came in at $0.50, falling short of the expected $0.8549. Growth remained robust in Mexico, Peru, and Colombia, but profitability suffered due to temporary margin pressure and billing penalties in Peru. The stock experienced a sharp decline of 13.65% in premarket trading, closing at $4.68, near the stock's 52-week low. Despite the earnings miss, demand remained strong across Auna's healthcare network in Latin America, with Mexico being a key growth engine. Revenue in Mexico grew 4% year-over-year and 5% sequentially, with surgeries increasing 7% from the prior quarter. Oncology services saw exceptional growth, with chemotherapy and radiotherapy volumes up 20% sequentially and oncology revenue up 110% year-over-year. Peru's revenue grew 8% year-over-year, driven by higher average ticket prices and membership expansion. Colombia delivered 13% revenue growth, with private payer revenue increasing 17% year-over-year. Capacity utilization improved in all three markets, indicating healthy demand. Adjusted EBITDA declined 9% FX-neutral, as the company faced margin pressure in Mexico and Colombia and accepted billing penalties in Peru. Management noted that these issues should not affect the company's long-term growth outlook. Adjusted earnings of $0.50 per share missed analyst expectations by $0.3549 per share, a 41.5% shortfall. Revenue beat exceeded expectations by $60 million, or 5.1%. The combination of revenue and earnings results suggests healthy demand but highlights cost pressures and margin challenges.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Earnings call transcript: Borosil Q1 2026 profit falls as margins narrow",
        "url": "https://urgent.news/2026/08/19/earnings-call-transcript-borosil-q1-2026-profit-falls-as-margins",
        "published": "2026-08-19T12:07:54.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}